A novel chemosensitivity profiling platform for small acute lymphoblastic leukemia cell populations

Major improvements in treatment and supportive care have resulted in survival rates close to 90% for acute lymphoblastic leukemia (ALL), the most common childhood cancer. However, 15–20% of patient...